Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-26

Clinical Trial Update: Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation

View source ↗

Summary

This clinical trial update explores whether inflammatory response can predict recurrence of atrial fibrillation after ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Warsaw | Conditions: Atrial Fibrillation | Status: UNKNOWN